Answers are grounded in this paper and cite their sources.
Evaluates clinical laboratory parameters in adolescents with moderate-to-severe atopic dermatitis, suggesting potential treatment outcomes.
ClinicalTrials.gov identifier, NCT03526861 (ECZTRA 6); study start date: June 19, 2018; primary completion date: April 15, 2020; study completion date: March 16, 2021.
No takes yet. Share an insight, caveat, or question.
Paller et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: